Tag: Bureau of Competition

Displaying 341 - 360 of 399 results.

By a 3-1-1 vote, the Federal Trade Commission today closed its investigation into Genzyme Corporation's (Genzyme) 2001 acquisition of Novazyme Pharmaceuticals, Inc. (Novazyme). At the time of its acquisition, Novazyme was engaged primarily in conducting early pre-clinical studies relating to...
The Federal Trade Commission has issued a unanimous policy statement on the use of monetary equitable remedies such as disgorgement and restitution in competition cases – specifically, those involving violations of the Hart-Scott-Rodino (HSR) Premerger Notification Act, the FTC Act, and the...
Presenting keynote remarks at an annual conference on "Current Topics in Merger and Antitrust Enforcement" in Washington, DC, today Federal Trade Commission Competition Director Joe Simons announced the Bureau's new "Guidelines for Merger Investigations," which are designed to incorporate recently...
The Federal Trade Commission today released the materials relating to the workshop on Health Care Competition Law and Policy, held on September 9-10, 2002. The workshop focused on the implications of competition law and policy for health care financing and delivery and considered the impact of...
The Federal Trade Commission today announced a proposed consent order with Bayer AG (Bayer) and Aventis S.A. (Aventis) that will allow Bayer's proposed purchase of Aventis's subsidiary Aventis CropScience Holdings S.A.
The Federal Trade Commission today approved publication of a Federal Register notice seeking public comments on the use of disgorgement as a remedy for competition violations, including those involving the Hart-Scott-Rodino (HSR) Premerger Notification Act, FTC Act, and Clayton Act.
The staff of the Federal Trade Commission has negotiated an agreement with The Hearst Corporation (Hearst), which staff will propose to the Commission as a way to settle a permanent injunction action filed by the FTC. According to the Commission's April 5, 2001 complaint, Hearst failed to provide...
The Federal Trade Commission today announced that The Hearst Trust and its wholly owned subsidiary, The Hearst Corporation (Hearst), have agreed to settle charges that it failed to include required documents in its premerger notification report concerning its 1998 acquisition of Medi-Span, Inc....

Pages